Rchr
J-GLOBAL ID:200901042654643850   Update date: Jun. 09, 2020

Arai Midori

アライ ミドリ | Arai Midori
Affiliation and department:
Job title: assistant professor
Homepage URL  (1): http://www.p.chiba-u.jp/lab/kassei/index.html
Research field  (3): Environmental and pharmaceutical development resources ,  Chemical biology ,  Pharmaceuticals - chemistry and drug development
Research keywords  (4): Biological Organic Chemistry ,  Chemical Pharmaceutics ,  Natural products ,  Chemical biology
Research theme for competitive and other funds  (1):
  • 2006 - 2007 Development of High-thoroughput analyzing system of vitamin D3 analogues
Papers (105):
  • Yusuke Yokoyama, Midori A. Arai, Yasumasa Hara, Masami Ishibashi. Identification of BMI1 promoter inhibitors from Streptomyces sp. IFM-11958. Bioorganic and Medicinal Chemistry. 2019. 27. 13. 2998-3003
  • Yusuke Yokoyama, Midori A. Arai, Yasumasa Hara, Masami Ishibashi. Nonactic Acid Derivatives Isolated from Streptomyces werraensis IFM12104 in a Screening Program for BMI1 Promoter Inhibitory Activity. Natural Product Communications. 2019. 14. 7
  • Yasumasa Hara, Midori A. Arai, Kazufumi Toume, Hyuma Masu, Tomoyuki Sato, Katsuko Komatsu, Takashi Yaguchi, Masami Ishibashi. Coculture of a Pathogenic Actinomycete and Animal Cells to Produce Nocarjamide, a Cyclic Nonapeptide with Wnt Signal-Activating Effect. Organic Letters. 2018. 20. 18. 5831-5834
  • Midori A Arai, Fumie Ochi, Yoshinori Makita, Tetsuhiro Chiba, Kyohei Higashi, Akiko Suganami, Yutaka Tamura, Toshihiko Toida, Atsushi Iwama, Samir K Sadhu, Firoj Ahmed, Masami Ishibashi. GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition. ACS chemical biology. 2018. 13. 9. 2551-2559
  • Arai Midori A, Masuda Ayaka, Suganami Akiko, Tamura Yutaka, Ishibashi Masami. Synthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance. CHEMICAL & PHARMACEUTICAL BULLETIN. 2018. 66. 8. 810-817
more...
MISC (17):
Patents (1):
  • Preparation of spirobisisoxazoline and their intermediates, and use of the spiro compounds as asymmetric catalysts
Works (2):
  • Design and synthesis of vitamin D3 analogues as drugs for prostate cancer
    2004 -
  • Development of high-thoroughput analyzing system of vitamin D3 analogues
    2004 -
Education (4):
  • 1997 - 2000 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
  • 1995 - 1997 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
  • 1991 - 1995 The University of Tokyo Faculty of Pharmaceutical Sciences
  • 1991 - 1995 The University of Tokyo Faculty of Pharmaceutical Science
Professional career (1):
  • Ph. D. (The University of Tokyo)
Work history (11):
  • 2008/04 - 現在 Graduate School of Pharmaceutical Sciences, Chiba University Associate Professor
  • 2018/04 - 2019/03 Shizuoka University Lecturer (part-time)
  • 2018/04 - 2019/03 Kyusyu University Lecturer (part-time)
  • 2013/08 - 2015/07 Grants-in-Aid for Scientific Research (KAKENHI), Ministry of Education, Culture, Sports, Science and Technology-Japan Program Officer
  • 2011/04 - 2013/03 Tokyo University of Pharmacy and Life Sciences Lecturer (part-time)
Show all
Awards (6):
  • 2019 - The Pharmaceutical Society of Japan Award for Divisional Scientific Promotion
  • 2014 - The SJWS (Society of Japanese Women Scientists) Promoting Scientific Award
  • 2012 - Asian Core Program (Cutting-Edge Organic Chemistry in Asia) Lectureship Award
  • 2011 - The Morita award of Japanese Association of University Women
  • 2010 - The Pharmaceutical Society of Japan Award for Young Scientists
Show all
Association Membership(s) (3):
The Chemical Society of JAPAN ,  The Society of Synthetic Organic Chemistry ,  The Pharmaceutical Society of Japan
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page